medigraphic.com
ISSN 2007-8013 (Print)
Órgano oficial de la Universidad Autónoma de Sinaloa

2023, Number 2

<< Back Next >>

Rev Med UAS 2023; 13 (2)

Association of sociodemographic and clinical factors with mental health disorders during the COVID-19 pandemic

Vega-López A, Nájera-Ruiz ÁS, Vega-Monsivais EA, Villegas-Domínguez JE, Márquez-Celedonio FG

Language: Spanish
References: 29
Page: 139-152
PDF size: 219.01 Kb.


ABSTRACT

Objective. To determine the association of sociodemographic and clinical factors with mental health disorders during the COVID-19 pandemic. Methodology. Analytical cross-sectional survey through the application of a questionnaire on sociodemographic and clinical factors and the DESS-21 instrument in the beneficiary population of the Mexican Navy Secretariat during the COVID-19 pandemic in 2022. Statistical analysis with Chi-square, Student's t, Mann-Whitney U, estimation of odds ratio and 95% confidence intervals. Results. We included 339 individuals aged 37.3 ± 2.7 years, 172 (50.7%) females. Prevalence of mental health disorders was 35.7%, 240 (29.2%), 88 anxiety (26.0%) and 83 depression (24.5%). Odds ratio and 95% CI 0.62 (0.39-097) in health workers; singles 1.96 (1.22-3.12); unemployed 2.7 (1.58-4.59); with Soledad 6.7 (4.07-10.9); self-perception of good health 0.26 (0.09-0.78); fear of getting sick 2.5 (1.56-3.98); family loss from COVID-19 4.85 (2.81-8.4); having COVID-19 3.22 (1.87-5.54); family with COVID-19 2.8 (1.19-6.56); alcoholism 2.1 (1.33-3.29) and use of anxiolytics 5.6 (1.96-15.9) Conclusions. The prevalence of mental health disorders during the COVID-19 pandemic was 35.7%; single or unjoined; feelings of loneliness, personal history of stress, anxiety and depression, history of alcoholism and use of anxiolytics, as well as having fallen ill or a family member and having had family losses from COVID-19 were associated as risk factors while being a health worker was a protective factor.


REFERENCES

  1. Zhu N, Zhang D, Wang W, Li X, Yang B, SongJ, et al. A Novel Coronavirus from Patients withPneumonia in China, 2019. N Engl J Med 2020; 382 (8): 727-733

  2. Doolan DL, Kozlakidis Z, Zhang Z, Paessler S,Su L, Yokota YT, et al. Editorial: CoronavirusDisease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and PublicHealth Response. Front. Public Health 2021;9:807159.

  3. World Health Organization. COVID-19 Weeklyepidemiological update. Edition 125, 11 January 2023

  4. Machhi J, Herskovitz J, Ahmed MS, Dutta D.The Natural History, Pathobiology, and ClinicalManifestations of SARS-CoV-2 Infections. JNeur Pharmacol. 2020; 15: 359–386

  5. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T,et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease2019 (COVID-19). JAMA Cardiol. 2020; 5 (7):811-818.

  6. Song Y, Liu P, Shi XL, Chu YL, Zhang J, Xia J,Gao XZ, Qu T, Wang MY. SARS-CoV-2 induced diarrhea as onset symptom inpatientwith COVID-19. Gut 2020; 69: 1143–1144

  7. Barnes GD, Burnett A, Allen A, Blumenstein M,Clark NP, Cuker A, et al. Thromboembolismand anticoagulant therapy during the COVID19 pandemic: interim clinical guidance fromthe anticoagulation forum. J Thromb Thrombolysis 2020; 50: 72–81

  8. Puelles VG, Lütgehetmann M, LindenmeyerMT, Sperhake JP, Wong MN, Allweiss L, et al.Multiorgan and renal tropism of SARS-CoV-2.N Engl J Med 2020: 383: 590-592

  9. Inciardi RM, Lupi L, Zaccone G, Italia L, RaffoM, Tomasoni D, et al. Cardiac involvement ina patient with Coronavirus disease 2019(COVID-19). JAMA Cardiol 2020; 5 (7): 819 –824

  10. Lola K. Global mental health and COVID-19.The Lancet, 2020; 7: 655-657.

  11. Asociación Americana de Psiquiatría. Guía deconsulta de los criterios diagnósticos del DSM5. American Psychiatric Publishing. Washington DC, 2014

  12. Holmes EA, O´Connor RC, Perry VH, TraceyI, Wessely S. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. LancetPsychiatr. 2020; 7: 547–60

  13. Rodríguez J, Kohn R, Aguilar S. Epidemiología de los trastornos mentales en América Latina y el Caribe [Internet]. Washington (DC):Organización Panamericana de la Salud; 2009(Publicación Científica y Técnica No.632)[consultado el 31 de enero del 2014].

  14. Usher K, Durkin J, Bhullar N. The COVID-19pandemic and mental health impacts. Int JMent Health Nurs. 2020; 29: 315–318

  15. Liang X, Zhu Y, Fang Y. COVID-19 and posttraumatic stress disorder: A vicious circle involving immunosuppression. CNS NeurosciTher. 2020; 26: 876–878

  16. Haider II, Tiwana F, Tahir SM. Impact of theCOVID-19 Pandemic on Adult Mental Health.Pak J Med Sci. 2020; 36: (COVID19-S4): S90-S94

  17. Vahia IV, Jeste DV, Reynolds III CF. OlderAdults and the Mental Health Effects ofCOVID-19. J Am Med Assoc. 2020; 324 (22):2253-2254

  18. Czeisler ME, Rashon I, Lane MA, Petrosky E,Wiley JE, Christensen A, et al. Mental health,substance use, and suicidal ideation duringthe COVID-19 pandemic. Morb Mortal WklyRep. 2020; 69 (32): 1049-1057.

  19. González-Sanguino C, Ausín B, CastellanosMA, Saiz J, López-Gómez A, Ugidos C, et al.Mental health consequences during the initialstage of the 2020 coronavirus pandemic(COVID-19) in Spain. Brain Behav Immun.

  20. 2020; 87: 172-176.20. Wang C, Pan R, Wan X, Tan Y, Xu L, McIntyreRS, et al. A longitudinal study on the mentalhealth of general population during theCOVID-19 epidemic in China. Brain, BehavImmun. 2020; 87: 40–48

  21. Hawes MT, Szenczy AK, Klein DN, Hajcak G,Nelson BD. Increases in depression and anxiety symptoms in adolescents and young adultsduring the COVID-19 pandemic. Psychol Med.2022; 52 (14): 3222-3230.

  22. Pierce M, Hope H, Ford T, Hatch S, Hotopf M,John A et al. Mental health before and duringthe COVID-19 pandemic: a longitudinal probability sample survey of the UK population. Lancet Psychiatr. 2020; 7: 883–892

  23. Losada-Baltar A, Jiménez-Gonzalo L,Gallego-Alberto L, Pedroso-Chaparro MS,Fernandes-Pires J, Márquez-González M.“We Are Staying at Home.” Association of Selfperceptions of Aging, Personal and Family Resources, and Loneliness With PsychologicalDistress During the Lock-Down Period ofCOVID-19. J Gerontol B Psychol Sci Soc.2021, 76 (2): e10-e16

  24. O´Connor RC, Wetherall K, Cleare S, McClelland H, Melson AJ. Mental health and well-being during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19Mental Health & Wellbeing study. Br J Psychiatr 2021; 218 (6): 326–333.

  25. Parola A, Rossi A, Tessitore F, Troisi G, Mannarini S. Mental Health Through the COVID-19Quarantine: A Growth Curve Analysis on Italian Young Adults. Front. Psychol 2020; 11:567484.

  26. Antúnez Z, Vinet EV. Escalas de depresión,ansiedad y Estrés (DASS-21): validación de laversión abreviada en estudiantes universitarios chilenos. Ter Psicol. 2012; 30 (3): 49 – 35

  27. Román F, Santibáñez P, Vinet EV. Uso de lasescalas de depresión, ansiedad, estrés(DASS-21) como instrumento de tamizaje enjóvenes con problemas clínicos. Acta InvestigPsicol. 2016; 6 (1): 2325-2336

  28. Das R, Hasan MR, Daria S, Islam R. Impactof COVID-19 pandemic on mental healthamong general Bangladeshi population: across- sectional study. BMJ Open 2021;11:e045727.

  29. Wang C, Tee M, Roy AE, Fardin MA, Srichokchatchawan W, Habib HA, et al. The impact of COVID-19 pandemic on physical andmental health of Asians: A study of seven middle-income countries in Asia. PLoS ONE 2021;16 (2): e0246824.




2020     |     www.medigraphic.com